MEDICA Newsletter
Social Media
More about…
- 3D-Druck
- Adipositas
- Alter
- Alternative Medizin
- Alzheimer
- Antibiotika
- Arthritis
- Arthrose
- Arzneimittel
- Asthma
- Augen
- Ausbildung
- Autismus
- Baby
- Behandlung
- Beleuchtung
- Bildgebung
- Biochip
- Biofeedback
- Biokompatibel
- Biomarker
- Biotechnologie
- Blase
- Blut
- Bluthochdruck
- Brust
- COPD
- CT
- Chirurgie
- Darm
- Defibrillator
- Demenz
- Depression
- Diabetes
- Diagnostik
- EEG
- EMG
- Eierstöcke
- Elektronische Patientenakte
- Epilepsie
- Erbmaterial
- Ernährung
- Fitness
- Forschung
- Frauen
- Früherkennung
- Geburt
- Gehirn
- Genetik
- Geräte
- Gynäkologie
- HPV
- Haut
- Hepatitis
- Herz
- Herz-Kreislauf
- Hirntumor
- Immunsystem
- Impfung
- Implantat
- Infektionskrankheit
- Influenza
- Informationstechnologie
- Intensivmedizin
- Kinder
- Knie
- Kommunikation
- Kongress
- Krankenhaus
- Krebs
- Künstliche Intelligenz
- Labor
- Laser
- Leber
- Leukämie
- Lunge
- MRT
- Magen
- Medizinische Apps
- Medizinmarkt
- Mikrosystemtechnik
- Minimal-Invasiv
- Multiple Sklerose
- Männer
- Nanotechnologie
- Neurologie
- Niere
- Notfallmedizin
- Operation
- Optimierung
- Optische Technologien
- Organe
- Orthopädie
- Parkinson
- Pathogene
- Pathologie
- Patienten
- Personalisierte Medizin
- Pflege
- Physiotherapie
- Polymere
- Prostata
- Prothese
- Psychologie
- Qualität
- Radiologie
- Regenerative Medizin
- Rehabilitation
- Rheuma
- Risiken
- Robotik
- Röntgengeräte
- Schlaganfall
- Schwangerschaft
- Screening
- Senioren
- Sepsis
- Sicherheit
- Sinne
- Smart textiles
- Software
- Sport
- Stammzellen
- Stent
- Telemedizin
- Therapie
- Tissue Engineering
- Toxikologie
- Tuberkulose
- Ultraschall
- Umwelt
- Verbände
- Virtual Reality
- Vorsorge
- Wearables
- Weltgesundheit
- Werkstoffe
- Wundheilung
- Zellen
- Ärzte
Diagnostic tool: AI for breast cancer
13.12.2019
Scientists are developing a new way to identify the unique chemical 'fingerprints' for different types of breast cancers. These new chemical footprints will be used to train AI software - creating a new tool for rapid and accurate diagnosis of breast cancers.
Imaging: ability to characterize healthy and non-healthy tissue
29.11.2019
In an article published in the peer-reviewed SPIE publication Journal of Biomedical Optics (JBO), "Influence of neoadjuvant chemotherapy on diffuse reflectance spectra of tissue in breast surgery specimens," research observed across 92 ex vivo breast specimens suggests that there is little to no impact on the optical signatures of breast tissue after neoadjuvant chemotherapy.
Cells: blocking metastasis-promoting enzyme
15.11.2019
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UC San Francisco scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.
Personalized cancer medicine: customized treatment
01.03.2018
Everyone is different. This statement also applies to our health. Cancer, in particular, can look and progress differently depending on the individual person. That’s why every patient ideally also needs a customized treatment that is tailored to their individual needs. But how feasible is this idea?